Glucose-dependent miR-125b is a negative regulator of ß-cell function (2021)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.05.17.444559
Publication URI: http://dx.doi.org/10.1101/2021.05.17.444559
Type: Preprint